• N&PD Moderators: Skorpio

N-methyl-D-aspartate receptor blockers anti convulsants

THE IDIOT

Greenlighter
Joined
Oct 14, 2013
Messages
2
well this little baby turned out pretty well, I guess when they get there the anti convulsant stuff might be a market in itself right?
a)
N-methyl-D-aspartate receptor blockers, non cannaboid receptor agonists that aren't synthetic cannaboids eg hu-211http://www.ncbi.nlm.nih.gov/pubmed/7477742


Is albert einstein in here, gonna jack the anti convulsant stuff create a market for himself with a non synthetic cannaboid…something like this

b)
cb2 receptor agonists,nmda antagonists anti convulsants that aren't synthetic cannaboids

Inviting ridicule, whats the anti convulsant potential in there?
 
that should of been....b) non cb1 receptor agonists, that are cb2 receptor agonists,nmda antagonists anti convulsants that aren't synthetic cannaboids
 
This is phrased pretty bizarrely. Are you looking for a cb2 selective agonist and nmda antagonist in the same compound? If so, why?
It's been long-standingly known that nmda-antagonism is useful for prevention of neurotoxicity in the wake of neural ischemia. . .

ebola
 
I wonder if HU-211 has a recreative potential as a dissociative? it's a pretty interesting compound actually.
 
Maybe he was asking why these things are anticonvulsants?

If that's the case, the reason why NMDA antagonists are anticonvulsants is due to the fact that the antagonist is blocking the effects of Glutamate at the NMDA Receptor. Glutamate causes excitation and by blocking it from working, there not enough excitation to induce convulsions.
 
Top